2018 Pasteur-Servier-Weizmann Prize Laureate
On October 16, 2018, at a ceremony at the Academy of Sciences, the Pasteur-Servier-Weizmann Prize was awarded to the research lab headed by Prof. Michel Sadelain. Prof. Sadelain is the director and founder of the cellular engineering center and head of the gene transfer and genetic expression lab at the Memorial Sloane-Kettering Cancer Center in New York (USA).
Prof. Sadelain is renowned worldwide for the concept, preclinical demonstration, and clinical application of a new immunotherapy for cancer, based on the utilization of synthetic receptors that he calls “chimeric antigen receptors” (CARs) and in particular the CARs targeting CD 19 (article in Nature – 2017;545:423-431).
Speakers at the mini colloquium 2018 “Immuno-regulation and cancer”
“Metastatic melanoma treatment: progresses, challenges and hope”
Professor Caroline ROBERT (INSERM U981; Chief of Dermatology at Gustave Roussy, Villejuif)
“Decoding the mode of action of tumor immunotherapies using intravital imaging”
Professor Philippe BOUSSO (Institut Pasteur Paris, Head of the structure, “dynamics of immune responses” Unit)
Immunotherapy for cancer treatment in the spotlight (Videos in French)
University of Indiana, Indianapolis.
University René-Descartes, Paris.
University of Colorado, Denver.
University of Toronto.
University of Manchester.
